chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: I got my 1st vaccine and April and noticed a really heavy period afterward but nothing to alarming. I track my cycle month and it's always very consistent and it follows an app on my phone. After I got my next vaccine  in May my following period came when it normally does but lasted 15 days straight instead of the usual 6. After 25 days it stopped for 4 days and then started up for another 4 days.  It wasn't spotting it was a full period. So the month of June I had a  19 days period. Next cycle came in July and it was normal
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in fingers and toes - tingling sensation - wrist - hand- finger- feet & toes. Weird headache  especially when I sleep.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Patient returned for her second Pfizer Covid vaccine on 7/20/21 and stated that she had been treated for a blood clot in her lung(s) on 7/12/21. She received her first Pfizer Covid vaccine on 6/29/21. Treatment for clot is ongoing
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis
Clinical narrative: After receiving the shot I have had headaches every day since receiving the vaccine.  I also sweat more profusely they I did before.  Water just runs off of me.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Head injury, Syncope
Clinical narrative: AFTER ABOUT 10  MIN. OF INJECTION,  AS THE PT. WAS WALKING TO SEAT OUSIDE OF CONSULTAION ROOM FOR ADDITIONAL 5 MINUTES, PT FAINTED AND HIT HIS HEAD TO THE DOOR FRAM. MOM HAD EPIPEN .3 MG AND PT WAS INJECTED INTO THE LEFT THIG.PT REGAINED CONSCOIUSNESS AFTER ABOUT 2 MINUTES PARAMEDICS ARRIVED AND EXAMINED THE  PT, WHICH WAS DOING OK. MOM TOOK HIM TO THE ER AND PT IS DOING OK AND RELEASED.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood iron decreased, Chills, Dysmenorrhoea, Fatigue
Clinical narrative: 6 hours after vaccine, I became weak and tired. I fell asleep. Woke up 12 hours post vaccine with fever of 102.4 (lasted about 6 hours) accompanied by aches, chills, viral rash on neck and trunk and arms. Headache noted at 4 hours post vaccine and lasted 6 days. Heavy menstrual bleeding and cramping despite being on continuous birth control pills in May. Cramping not relieved by 600-800mg ibuprofen and 1000mg Tylenol every 4-6 hours. Usually my period is completely suppressed with the birth control but now and having break through cycles lasting 10-14 days. Viral rash noted again 7/10 during the 14-day menstrual cycle.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count normal, Headache, Heavy menstrual bleeding, Menstrual disorder, Metabolic function test normal
Clinical narrative: 6 hours after vaccine, I became weak and tired. I fell asleep. Woke up 12 hours post vaccine with fever of 102.4 (lasted about 6 hours) accompanied by aches, chills, viral rash on neck and trunk and arms. Headache noted at 4 hours post vaccine and lasted 6 days. Heavy menstrual bleeding and cramping despite being on continuous birth control pills in May. Cramping not relieved by 600-800mg ibuprofen and 1000mg Tylenol every 4-6 hours. Usually my period is completely suppressed with the birth control but now and having break through cycles lasting 10-14 days. Viral rash noted again 7/10 during the 14-day menstrual cycle.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pregnancy test negative, Pyrexia, Rash, Viral rash
Clinical narrative: 6 hours after vaccine, I became weak and tired. I fell asleep. Woke up 12 hours post vaccine with fever of 102.4 (lasted about 6 hours) accompanied by aches, chills, viral rash on neck and trunk and arms. Headache noted at 4 hours post vaccine and lasted 6 days. Heavy menstrual bleeding and cramping despite being on continuous birth control pills in May. Cramping not relieved by 600-800mg ibuprofen and 1000mg Tylenol every 4-6 hours. Usually my period is completely suppressed with the birth control but now and having break through cycles lasting 10-14 days. Viral rash noted again 7/10 during the 14-day menstrual cycle.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased, Chest pain, Dizziness, Electrocardiogram
Clinical narrative: At about 30 minutes after injection, pt complained of light dizziness. We had her wait additional minutes.  I checked on her several times. She felt no urgency to call an ambulance. A family member was going to  pick her up.  I checked with her again- She complained of slight chest pain.  We have a walk-in clinic in our store- I walked her over to the clinic. We called the ambulance from the clinic. Her blood pressure was slightly elevated. She was not clammy or short of breath. I left her at the clinic where she was transported to the ER.  I spoke to pt at 9:01 pm.  She had just returned home from the ER- She said They ran and EKG at the hospital and gave her Nitroglycerin Tabs.  They found no problems with her heart and stated they felt it was anxiety.  She told me she felt no anxiety.  Just was glad she was getting her 2nd shot
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Skin warm, Swelling
Clinical narrative: Very large red  raised bump about 3?X2?  that did not go away for 3-4 days .  Did not go away with Benadryl. Not itchy or painful but hard to touch and warm.
Age: 17.0
Sex: F
Vaccine: COVID19, MEN
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse event 17 year old was given vaccine not yet FDA approved. Delay in receiving #2 vaccine
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No Adverse event reported by patient.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No Adverse event reported by patient.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: no Adverse event reported by patient.
Age: 39.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: no Adverse event reported by patient.
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: no Adverse event reported by patient.
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No Adverse event reported by patient.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Erythema, Induration
Clinical narrative: 10cm x 9.5cm area of redness & induration. Pt. given Benadryl & ibuprofen. HC cream applied to area.
Age: 72.0
Sex: F
Vaccine: HEPA, PNC13, VARZOS
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Redness at injection site, complains of itchiness at injection site.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse medical reaction.  The patient is 17 years old, too young for the Moderna vaccine We have contacted the health department and moderna
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dysphagia, Throat tightness
Clinical narrative: I had an immediate reaction right after the vaccine. I was waiting in the holding room, I had difficulity hearing and focusing. I could barely stand and very thirsty. I was given 2 shots of Epinephrine and an ambulance was called. I did not want to go with the ambulance so I stayed behind at the medical office for 6 hours. I finally felt well enough and someone drove me home. My blood pressure was fine at the time. 2 weeks later, I checked my blood pressure and it was high at 190/101. It stayed elevated for 2 weeks and then normalized. About 1 month after the vaccine, I started to notice changes in my vision. I initally visited my PCP to check my blood pressure and also discussed changes in my vision. He did blood work which was normal. So I went to see my optometrist and did an eye exam, which he noted significant changes in my vision. My reading eye sight did not change but my farsightedness had significant changes and I now have to wear glasses for farsightedness. Before I was able see and read signs on the road far away and now I can not. My vision seeing far is very blurry.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disturbance in attention, Hypertension, Hypoacusis, Immediate post-injection reaction, Laboratory test normal
Clinical narrative: I had an immediate reaction right after the vaccine. I was waiting in the holding room, I had difficulity hearing and focusing. I could barely stand and very thirsty. I was given 2 shots of Epinephrine and an ambulance was called. I did not want to go with the ambulance so I stayed behind at the medical office for 6 hours. I finally felt well enough and someone drove me home. My blood pressure was fine at the time. 2 weeks later, I checked my blood pressure and it was high at 190/101. It stayed elevated for 2 weeks and then normalized. About 1 month after the vaccine, I started to notice changes in my vision. I initally visited my PCP to check my blood pressure and also discussed changes in my vision. He did blood work which was normal. So I went to see my optometrist and did an eye exam, which he noted significant changes in my vision. My reading eye sight did not change but my farsightedness had significant changes and I now have to wear glasses for farsightedness. Before I was able see and read signs on the road far away and now I can not. My vision seeing far is very blurry.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ophthalmological examination, Thirst, Vision blurred, Visual impairment
Clinical narrative: I had an immediate reaction right after the vaccine. I was waiting in the holding room, I had difficulity hearing and focusing. I could barely stand and very thirsty. I was given 2 shots of Epinephrine and an ambulance was called. I did not want to go with the ambulance so I stayed behind at the medical office for 6 hours. I finally felt well enough and someone drove me home. My blood pressure was fine at the time. 2 weeks later, I checked my blood pressure and it was high at 190/101. It stayed elevated for 2 weeks and then normalized. About 1 month after the vaccine, I started to notice changes in my vision. I initally visited my PCP to check my blood pressure and also discussed changes in my vision. He did blood work which was normal. So I went to see my optometrist and did an eye exam, which he noted significant changes in my vision. My reading eye sight did not change but my farsightedness had significant changes and I now have to wear glasses for farsightedness. Before I was able see and read signs on the road far away and now I can not. My vision seeing far is very blurry.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Flushing, Paraesthesia, Pruritus, Urticaria
Clinical narrative: 15 minutes after injection, hives; red skin; feeling flushed; itchy; tight skin; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 20:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included, the patient was allergic to iodine-based  x-ray with contrast dye. Concomitant medications included, multivitamin (MANUFACTURER UNKNOWN), magnesium calcium supplement (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination the patient had not been tested for COVID-19 . On  23Mar2021,after 15min of vaccination, at 20:15 the patient experienced hives, red skin, feeling flushed, itchy and tight skin. Therapeutic measures included treatment with Benadryl tablet. The clinical outcome of the event hives, red skin, itchy, feeling flushed, tight skin were recovered.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Flushing, Pruritus, Skin tightness, Urticaria
Clinical narrative: 15 minutes after injection, hives; red skin; feeling flushed; itchy; tight skin; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 20:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included, the patient was allergic to iodine-based  x-ray with contrast dye. Concomitant medications included, multivitamin (MANUFACTURER UNKNOWN), magnesium calcium supplement (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination the patient had not been tested for COVID-19 . On  23Mar2021,after 15min of vaccination, at 20:15 the patient experienced hives, red skin, feeling flushed, itchy and tight skin. Therapeutic measures included treatment with Benadryl tablet. The clinical outcome of the event hives, red skin, itchy, feeling flushed, tight skin were recovered.  No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Tinnitus, Tongue disorder
Clinical narrative: Horrible tinnitus; Large bumps on back of tongue; This is a spontaneous report from a contactable consumer (patient). A 75-year-old non-pregnant female patient received bnt162b2 (Lot Number: EP G955), dose 1 via an unspecified route of administration, administered in left arm on 24Mar2021 10:30 (at the age of 75 years old) as single dose for covid-19 immunization. Medical history included deaf left ear, hearing loss right ear, acoustic neuroma left ear. The patient had unspecified known allergies. The patient's concomitant medications were not reported. No other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. The patient experienced horrible tinnitus and large bumps on back of tongue on 26Mar2021 21:00, which were resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. AE treatment included methylprednisolone (MEDROL) dose pack. The outcome of events was not recovered.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Tongue disorder
Clinical narrative: Horrible tinnitus; Large bumps on back of tongue; This is a spontaneous report from a contactable consumer (patient). A 75-year-old non-pregnant female patient received bnt162b2 (Lot Number: EP G955), dose 1 via an unspecified route of administration, administered in left arm on 24Mar2021 10:30 (at the age of 75 years old) as single dose for covid-19 immunization. Medical history included deaf left ear, hearing loss right ear, acoustic neuroma left ear. The patient had unspecified known allergies. The patient's concomitant medications were not reported. No other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. The patient experienced horrible tinnitus and large bumps on back of tongue on 26Mar2021 21:00, which were resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. AE treatment included methylprednisolone (MEDROL) dose pack. The outcome of events was not recovered.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Pain in extremity
Clinical narrative: Chest pain; Chest tightness; Sore arm; Chills; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergy to some shellfish. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 13:00, a couple of hours after injection the patient experienced sore arm and experienced chills around 17:00 to 19:00. The adverse effect sore arm was expected by the patient. The event sore arm was continued from 30Mar2021 to 31Mar2021. On 01Apr2021 around 02:00, the patient experienced chest pain on both sides of front and back. The chest pain can be described as tightness and two sharp pain sources inside the chest one in each chest side. Due to chest pain the patient woke up from sleep, oxymeter (oxygen saturation) showed normal 94 to 95% and heart beats were at 89 to 110 beats per minute (bpm). The patient thought it was enough pain to consider taking two ibuprofen (ADVIL), but the patient took one instead just in case the patient was having a heart attack. The patient had never experienced chest tightness or pain like that before. The pain had slowly subsided after taking one ibuprofen (ADVIL). The clinical outcome of the events sore arm was resolved on 31Mar2021; chest pain and chest tightness were resolved on 01Apr2021 at 05:00 and chills was resolved on an unknown date in 2021.  The reporter's assessment of the causal relationship of the sore arm with the suspect product was associated (expected).  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Heart rate, Oxygen saturation
Clinical narrative: Chest pain; Chest tightness; Sore arm; Chills; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergy to some shellfish. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 13:00, a couple of hours after injection the patient experienced sore arm and experienced chills around 17:00 to 19:00. The adverse effect sore arm was expected by the patient. The event sore arm was continued from 30Mar2021 to 31Mar2021. On 01Apr2021 around 02:00, the patient experienced chest pain on both sides of front and back. The chest pain can be described as tightness and two sharp pain sources inside the chest one in each chest side. Due to chest pain the patient woke up from sleep, oxymeter (oxygen saturation) showed normal 94 to 95% and heart beats were at 89 to 110 beats per minute (bpm). The patient thought it was enough pain to consider taking two ibuprofen (ADVIL), but the patient took one instead just in case the patient was having a heart attack. The patient had never experienced chest tightness or pain like that before. The pain had slowly subsided after taking one ibuprofen (ADVIL). The clinical outcome of the events sore arm was resolved on 31Mar2021; chest pain and chest tightness were resolved on 01Apr2021 at 05:00 and chills was resolved on an unknown date in 2021.  The reporter's assessment of the causal relationship of the sore arm with the suspect product was associated (expected).  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Chest pain; Chest tightness; Sore arm; Chills; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergy to some shellfish. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 13:00, a couple of hours after injection the patient experienced sore arm and experienced chills around 17:00 to 19:00. The adverse effect sore arm was expected by the patient. The event sore arm was continued from 30Mar2021 to 31Mar2021. On 01Apr2021 around 02:00, the patient experienced chest pain on both sides of front and back. The chest pain can be described as tightness and two sharp pain sources inside the chest one in each chest side. Due to chest pain the patient woke up from sleep, oxymeter (oxygen saturation) showed normal 94 to 95% and heart beats were at 89 to 110 beats per minute (bpm). The patient thought it was enough pain to consider taking two ibuprofen (ADVIL), but the patient took one instead just in case the patient was having a heart attack. The patient had never experienced chest tightness or pain like that before. The pain had slowly subsided after taking one ibuprofen (ADVIL). The clinical outcome of the events sore arm was resolved on 31Mar2021; chest pain and chest tightness were resolved on 01Apr2021 at 05:00 and chills was resolved on an unknown date in 2021.  The reporter's assessment of the causal relationship of the sore arm with the suspect product was associated (expected).  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm at inject site; This is a spontaneous report from a contactable consumer.  A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 5318), via an unspecified route of administration on 30Mar2021 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, starting about 10 hours after the vaccination, the patient experienced sore arm at the injected site which lasted until evening the following day. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sore arm at inject site was recovered on 01Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm at inject site; This is a spontaneous report from a contactable consumer.  A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 5318), via an unspecified route of administration on 30Mar2021 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, starting about 10 hours after the vaccination, the patient experienced sore arm at the injected site which lasted until evening the following day. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event sore arm at inject site was recovered on 01Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a non-contactable consumer. A 38-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VCCINE; Lot number: EP6955), via an unspecified route of administration on 30Mar2021 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had known allergies to tree nuts. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID-19 vaccine. On 31Mar2021, the patient experienced sore arm next day after injection. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment received for the reported event. The clinical outcome of the event sore arm was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: The right side of my face became numb from my forehead to chin; This is a spontaneous report from a contactable other healthcare professional, the patient. A 49-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the right arm on 01Apr2021 at 13:30 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included insulin sensitivity. The patient had reported latex allergy. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), lorazepam (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN), all taken from unknown dates and for unspecified indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 01Apr2021 at 14:00, 30 minutes post vaccine, the patient experienced numbness on the right side of the face from forehead to chin. The numbness had lasted for several hours. The sensations were very similar to numbness and associated after effects experienced after a shot of novocaine during dental work. The event neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the event numbness on the right side of the face from forehead to chin was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: The right side of my face became numb from my forehead to chin; This is a spontaneous report from a contactable other healthcare professional, the patient. A 49-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the right arm on 01Apr2021 at 13:30 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included insulin sensitivity. The patient had reported latex allergy. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), lorazepam (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN), all taken from unknown dates and for unspecified indications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 01Apr2021 at 14:00, 30 minutes post vaccine, the patient experienced numbness on the right side of the face from forehead to chin. The numbness had lasted for several hours. The sensations were very similar to numbness and associated after effects experienced after a shot of novocaine during dental work. The event neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient did not receive any treatment for the events experienced. The clinical outcome of the event numbness on the right side of the face from forehead to chin was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Axillary pain, Cough, Dizziness, Erythema
Clinical narrative: Swelling vaccinated arm (3-4 circumference); Redness; Swollen lymph nodes in arm pit; Joint pain; Muscle pain; Tired; Dizzy; Hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 in march2020, DVT (deep vein thrombosis), pulmonary embolism, depression, migraine, cluster headaches and vocal cord dysfunction. The patient was allergic to steroids, tetanus, Compazine, apples and pineapple. Concomitant medications included sertraline hydrochloride (ZOLOFT) started on an unknown date for unknown indication, rivaroxaban (XARELTO) started on an unknown date for unknown indication, gabapentin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, verapamil hydrochloride (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, olanzapine (OLANZ) started on an unknown date for unknown indication and pantoprazole sodium sesquihydrate (PROTONIX) started on an unknown date for unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:30 the patient experienced swelling in the vaccinated arm (3-4 circumference), redness, hot to touch, swollen lymph nodes in arm pit, joint pain, muscle pain, tiredness and became dizzy. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events swelling arm, redness, swollen lymph nodes, joint pain, muscle pain, tiredness, dizzy and warm skin were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Gastrooesophageal reflux disease, Headache, Lymph node pain, Musculoskeletal stiffness
Clinical narrative: Swelling vaccinated arm (3-4 circumference); Redness; Swollen lymph nodes in arm pit; Joint pain; Muscle pain; Tired; Dizzy; Hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 in march2020, DVT (deep vein thrombosis), pulmonary embolism, depression, migraine, cluster headaches and vocal cord dysfunction. The patient was allergic to steroids, tetanus, Compazine, apples and pineapple. Concomitant medications included sertraline hydrochloride (ZOLOFT) started on an unknown date for unknown indication, rivaroxaban (XARELTO) started on an unknown date for unknown indication, gabapentin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, verapamil hydrochloride (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, olanzapine (OLANZ) started on an unknown date for unknown indication and pantoprazole sodium sesquihydrate (PROTONIX) started on an unknown date for unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:30 the patient experienced swelling in the vaccinated arm (3-4 circumference), redness, hot to touch, swollen lymph nodes in arm pit, joint pain, muscle pain, tiredness and became dizzy. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events swelling arm, redness, swollen lymph nodes, joint pain, muscle pain, tiredness, dizzy and warm skin were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Rash erythematous, Respiratory tract congestion, Skin warm, Ultrasound Doppler
Clinical narrative: Swelling vaccinated arm (3-4 circumference); Redness; Swollen lymph nodes in arm pit; Joint pain; Muscle pain; Tired; Dizzy; Hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 in march2020, DVT (deep vein thrombosis), pulmonary embolism, depression, migraine, cluster headaches and vocal cord dysfunction. The patient was allergic to steroids, tetanus, Compazine, apples and pineapple. Concomitant medications included sertraline hydrochloride (ZOLOFT) started on an unknown date for unknown indication, rivaroxaban (XARELTO) started on an unknown date for unknown indication, gabapentin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, verapamil hydrochloride (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, olanzapine (OLANZ) started on an unknown date for unknown indication and pantoprazole sodium sesquihydrate (PROTONIX) started on an unknown date for unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:30 the patient experienced swelling in the vaccinated arm (3-4 circumference), redness, hot to touch, swollen lymph nodes in arm pit, joint pain, muscle pain, tiredness and became dizzy. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events swelling arm, redness, swollen lymph nodes, joint pain, muscle pain, tiredness, dizzy and warm skin were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound Doppler normal
Clinical narrative: Swelling vaccinated arm (3-4 circumference); Redness; Swollen lymph nodes in arm pit; Joint pain; Muscle pain; Tired; Dizzy; Hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 in march2020, DVT (deep vein thrombosis), pulmonary embolism, depression, migraine, cluster headaches and vocal cord dysfunction. The patient was allergic to steroids, tetanus, Compazine, apples and pineapple. Concomitant medications included sertraline hydrochloride (ZOLOFT) started on an unknown date for unknown indication, rivaroxaban (XARELTO) started on an unknown date for unknown indication, gabapentin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, verapamil hydrochloride (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, olanzapine (OLANZ) started on an unknown date for unknown indication and pantoprazole sodium sesquihydrate (PROTONIX) started on an unknown date for unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:30 the patient experienced swelling in the vaccinated arm (3-4 circumference), redness, hot to touch, swollen lymph nodes in arm pit, joint pain, muscle pain, tiredness and became dizzy. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events swelling arm, redness, swollen lymph nodes, joint pain, muscle pain, tiredness, dizzy and warm skin were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dizziness, Erythema, Fatigue, Lymphadenopathy
Clinical narrative: Swelling vaccinated arm (3-4 circumference); Redness; Swollen lymph nodes in arm pit; Joint pain; Muscle pain; Tired; Dizzy; Hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 in march2020, DVT (deep vein thrombosis), pulmonary embolism, depression, migraine, cluster headaches and vocal cord dysfunction. The patient was allergic to steroids, tetanus, Compazine, apples and pineapple. Concomitant medications included sertraline hydrochloride (ZOLOFT) started on an unknown date for unknown indication, rivaroxaban (XARELTO) started on an unknown date for unknown indication, gabapentin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, verapamil hydrochloride (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, olanzapine (OLANZ) started on an unknown date for unknown indication and pantoprazole sodium sesquihydrate (PROTONIX) started on an unknown date for unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:30 the patient experienced swelling in the vaccinated arm (3-4 circumference), redness, hot to touch, swollen lymph nodes in arm pit, joint pain, muscle pain, tiredness and became dizzy. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events swelling arm, redness, swollen lymph nodes, joint pain, muscle pain, tiredness, dizzy and warm skin were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Peripheral swelling, Skin warm
Clinical narrative: Swelling vaccinated arm (3-4 circumference); Redness; Swollen lymph nodes in arm pit; Joint pain; Muscle pain; Tired; Dizzy; Hot to touch; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 28Mar2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 in march2020, DVT (deep vein thrombosis), pulmonary embolism, depression, migraine, cluster headaches and vocal cord dysfunction. The patient was allergic to steroids, tetanus, Compazine, apples and pineapple. Concomitant medications included sertraline hydrochloride (ZOLOFT) started on an unknown date for unknown indication, rivaroxaban (XARELTO) started on an unknown date for unknown indication, gabapentin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, verapamil hydrochloride (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication, olanzapine (OLANZ) started on an unknown date for unknown indication and pantoprazole sodium sesquihydrate (PROTONIX) started on an unknown date for unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:30 the patient experienced swelling in the vaccinated arm (3-4 circumference), redness, hot to touch, swollen lymph nodes in arm pit, joint pain, muscle pain, tiredness and became dizzy. The event resulted in emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events swelling arm, redness, swollen lymph nodes, joint pain, muscle pain, tiredness, dizzy and warm skin were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Injection site pain, Pain, Paraesthesia, Pyrexia
Clinical narrative: Body aches; Sore arm; Tiredness; Tingling all over; Slight fever up to 101 degrees; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7543) via an unspecified route of administration in the left arm on 26Mar2021 at 15:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6198) via an unspecified route of administration in the left arm on 05Mar2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 27Mar2021 at 11:00, the patient had sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees. The clinical outcomes of the events sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Fatigue, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Body aches; Sore arm; Tiredness; Tingling all over; Slight fever up to 101 degrees; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7543) via an unspecified route of administration in the left arm on 26Mar2021 at 15:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6198) via an unspecified route of administration in the left arm on 05Mar2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 27Mar2021 at 11:00, the patient had sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees. The clinical outcomes of the events sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; Sore arm; Tiredness; Tingling all over; Slight fever up to 101 degrees; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7543) via an unspecified route of administration in the left arm on 26Mar2021 at 15:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6198) via an unspecified route of administration in the left arm on 05Mar2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 27Mar2021 at 11:00, the patient had sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees. The clinical outcomes of the events sore arm, tiredness, body aches, tingling all over and slight fever up to 101 degrees were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.